LFMT vs Placebo in New Biologic Start for Ulcerative Colitis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LFMT vs Placebo in New Biologic Start for Ulcerative Colitis — Stella

Recruiting

Back to Ulcerative Colitis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

University of Alberta Hospital, Edmonton, Alberta

Key details

Phase

Safety & dosing

Sponsor

University of Alberta

Enrollment target

~40 participants

Started

June 2022

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov